4SC Discovery GmbH 4SC Discovery GmbH, based in Planegg-Martinsried near Munich/Germany, is a wholly-owned subsidiary of 4SC AG. 4SC Discovery specializes in the early-stage research and discovery of novel therapeutic compounds against cancer and autoimmune diseases. 4SC Discovery offers its technologies and research services to other companies and engages in partnerships with pharmaceutical and biotech companies to accelerate the development and commercialization of its own early-stage therapeutic programs.
Partnering To leverage its existing programs and to strengthen the maturity of its pipeline, Panoptes Pharma has implemented a comprehensive partnering and in-/out-licensing strategy. Panoptes will partner its projects with small and large pharmaceutical or biotech companies. Please contact us for further information.